This project proposes to study neutralizing antibody responses to the two major infectious forms of vaccinia virus, the intracellular mature virus (IMV) and the extracellular enveloped virus (EEV). Neutralizing activity in vaccinia immune globulin will be fractionated using proteins and peptides. Reverse genetics will also be used to decipher structure-function relationship in IMV and EEV envelope glycoproteins.

Agency
National Institute of Health (NIH)
Institute
Center for Biologics Evaluation and Resarch - Viral Products (CBERVP)
Type
Intramural Research (Z01)
Project #
1Z01BK009011-01
Application #
6679012
Study Section
(LAIR)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost